We are live on
!
Find out more
Marex Group Portfolio holdings
AUM
$23.6B
Turnover
47.63%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+4.95%
1 Year Est. Return
+57.16%
3 Year Est. Return
+254.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.8B
AUM Growth
-$67.5M
(-0.42%)
Cap. Flow
+$1.48B
Cap. Flow
% of AUM
9.36%
Top 10 Holdings %
Top 10 Hldgs %
30.69%
Holding
1,298
New
335
Increased
347
Reduced
276
Closed
290
Avg Time Held Equity + Options
0.7
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.5
years
Avg Time Held Equity only
0.7
years
Top 10 Avg Time Held Equity only
0.6
years
Top 20 Avg Time Held Equity only
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lumentum
LITE
|
+$471M |
| 2 |
Sandisk
SNDK
|
+$313M |
| 3 |
Goldman Sachs
GS
|
+$179M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$144M |
| 5 |
Eli Lilly
LLY
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$304M |
| 2 |
UnitedHealth
UNH
|
+$174M |
| 3 |
NVIDIA
NVDA
|
+$137M |
| 4 |
Home Depot
HD
|
+$131M |
| 5 |
Netflix
NFLX
|
+$107M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.11% |
| 2 | Technology | 25% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 4.76% |
| 5 | Healthcare | 4.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
551
PUT
Airbnb
ABNB
$103B
| $657K | ﹤0.01% |
5,200
| – | – |
2025 Q3
2 quarters
|
|
552
Repligen
RGEN
$11.1B
| $656K | ﹤0.01% |
+5,572
| New | +$778K |
2026 Q1
0 quarters
|
|
553
Zillow
Z
$7B
| $653K | ﹤0.01% |
15,792
-22,423
| -59% | -$1.19M |
2022 Q4
13 quarters
|
|
554
American Express
AXP
$214B
| $653K | ﹤0.01% |
2,160
-148,530
| -99% | -$49.8M |
2025 Q3
2 quarters
|
|
555
iShares Core S&P Small-Cap ETF
IJR
$103B
| $651K | ﹤0.01% |
5,237
+269
| +5% | +$34.2K |
2024 Q4
5 quarters
|
|
556
Dollar General
DG
$29.7B
| $650K | ﹤0.01% |
5,477
+3,457
| +171% | +$493K |
2025 Q4
1 quarter
|
|
557
Celsius Holdings
CELH
$7.26B
| $649K | ﹤0.01% |
18,297
-122,609
| -87% | -$5.81M |
2025 Q4
1 quarter
|
|
558
Neurocrine Biosciences
NBIX
$13.9B
| $648K | ﹤0.01% |
4,920
+768
| +18% | +$102K |
2025 Q3
2 quarters
|
|
559
APA Corp
APA
$16.8B
| $646K | ﹤0.01% |
15,221
-20,795
| -58% | -$629K |
2023 Q4
9 quarters
|
|
560
3M
MMM
$85B
| $644K | ﹤0.01% |
4,433
+2,731
| +160% | +$435K |
2025 Q4
1 quarter
|
|
561
Curtiss-Wright
CW
$18.5B
| $638K | ﹤0.01% |
+937
| New | +$623K |
2026 Q1
0 quarters
|
|
562
PTC Therapeutics
PTCT
$4.98B
| $636K | ﹤0.01% |
+9,334
| New | +$661K |
2026 Q1
0 quarters
|
|
563
XP
XP
$14.9B
| $629K | ﹤0.01% |
33,011
-18,904
| -36% | -$365K |
2025 Q3
2 quarters
|
|
564
argenx
ARGX
$51.3B
| $627K | ﹤0.01% |
858
+257
| +43% | +$201K |
2025 Q4
1 quarter
|
|
565
American Exceptionalism Acquisition Corp
AEXA
$527M
| $623K | ﹤0.01% |
57,560
-15,786
| -22% | -$179K |
2025 Q3
2 quarters
|
|
566
BHP
BHP
$213B
| $623K | ﹤0.01% |
8,558
-1,417
| -14% | -$100K |
2025 Q4
1 quarter
|
|
567
Alliance Resource Partners
ARLP
$3.29B
| $617K | ﹤0.01% |
+22,300
| New | +$577K |
2026 Q1
0 quarters
|
|
568
Wayfair
W
$15.1B
| $615K | ﹤0.01% |
8,173
+3,976
| +95% | +$360K |
2022 Q4
13 quarters
|
|
569
MINISO
MNSO
$3B
| $614K | ﹤0.01% |
37,900
| – | – |
2025 Q4
1 quarter
|
|
570
Carnival Corporation Ltd
CCL
$35.8B
| $611K | ﹤0.01% |
23,626
+13,166
| +126% | +$384K |
2022 Q4
13 quarters
|
|
571
The Mosaic Company
MOS
$5.95B
| $609K | ﹤0.01% |
23,891
-3,127
| -12% | -$85.8K |
2023 Q3
10 quarters
|
|
572
Alignment Healthcare
ALHC
$1.72B
| $608K | ﹤0.01% |
34,500
+5,000
| +17% | +$100K |
2025 Q4
1 quarter
|
|
573
Global Payments
GPN
$22.2B
| $604K | ﹤0.01% |
8,980
+110
| +1% | +$8.11K |
2025 Q3
2 quarters
|
|
574
Celestica
CLS
$38.5B
| $603K | ﹤0.01% |
+2,142
| New | +$621K |
2026 Q1
0 quarters
|
|
575
West Pharmaceutical
WST
$27B
| $603K | ﹤0.01% |
2,407
+900
| +60% | +$224K |
2025 Q4
1 quarter
|
|
Similar funds
Marex Group's Q1 2026 Portfolio in Review
As of Q1 2026, Marex Group held 1,298 positions worth $15.8B, down 0.42% from $15.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Marex Group deployed $1.48B of net new capital in Q1 2026, opening 335 new positions and adding to 347 existing holdings. Its largest new stake was Lumentum: 857,171 shares worth $602M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $304M trimmed.
- Marex Group's largest Q1 2026 buy was Lumentum: 857,171 shares worth $602M.
- Marex Group added most to Goldman Sachs in Q1 2026, an estimated $179M increase.
- Marex Group's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $304M.
- Marex Group fully exited Dycom Industries in Q1 2026, selling an estimated $13.3M.
- Marex Group's ten largest holdings make up 31% of its $15.8B portfolio in Q1 2026.
- Marex Group opened 335 new positions and closed 290 in Q1 2026.
- Marex Group's portfolio value fell 0.42% quarter-over-quarter to $15.8B.
Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.